Evidence map›Paper›PMID 34531857›Full record

ArticleFrontiers in immunology2021

Partially Hydrolysed Whey Has Superior Allergy Preventive Capacity Compared to Intact Whey Regardless of Amoxicillin Administration in Brown Norway Rats.

Katrine Bækby Graversen, Jeppe Madura Larsen, Signe Schultz Pedersen, Laila Vestergaard Sørensen, Heidi Frahm Christoffersen, Lotte Neergaard Jacobsen, Susanne Halken, Tine Rask Licht, Martin Iain Bahl, Katrine Lindholm Bøgh

Abstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A Systematic Review to Reassess the Formula for Early Life Growth.Advances in nutrition (Bethesda, Md.) · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katrine Bækby GraversenNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Jeppe Madura LarsenNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Signe Schultz PedersenNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Laila Vestergaard SørensenResearch & Development, Arla Foods Ingredients Group P/S, Videbæk, Denmark.
Heidi Frahm ChristoffersenResearch & Development, Arla Foods Ingredients Group P/S, Videbæk, Denmark.
Lotte Neergaard JacobsenStrategic Business Unit Pediatric, Arla Foods Ingredients Group P/S, Viby J, Denmark.
Susanne HalkenHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Tine Rask LichtNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Martin Iain BahlNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Katrine Lindholm BøghNational Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It remains largely unknown how physicochemical properties of hydrolysed infant formulas influence their allergy preventive capacity, and results from clinical and animal studies comparing the preventive capacity of hydrolysed infant formula with conventional infant formula are inconclusive. Thus, the use of hydrolysed infant formula for allergy prevention in atopy-prone infants is highly debated. Furthermore, knowledge on how gut microbiota influences allergy prevention remains scarce. Objective: To gain knowledge on (1) how physicochemical properties of hydrolysed whey products influence the allergy preventive capacity, (2) whether host microbiota disturbance influences allergy prevention, and (3) to what extent hydrolysed whey products influence gut microbiota composition. Methods: The preventive capacity of four different Results: Two partially hydrolysed whey products with different physicochemical characteristics were found to be superior in preventing whey-specific sensitisation compared to intact and extensively hydrolysed whey products. Daily oral amoxicillin administration, initiated one week prior to intervention with whey products, disturbed the gut microbiota but did not impair the prevention of whey-specific sensitisation. The Conclusions: Our results support the use of partially hydrolysed whey products for prevention of cow's milk allergy in atopy-predisposed infants regardless of their microbiota status. However, possible direct effects of partially hydrolysed whey products on gut microbiota composition warrants further investigation.

Indexed as

Gastrointestinal MicrobiomeMilk HypersensitivityAmoxicillinAnimalsHumansProtein HydrolysatesRatsWhey ProteinsAmoxicillinProtein HydrolysatesWhey Proteinsallergy preventioncow’s milk allergyfood allergyhypoallergenic infant formulaIgAiTregmicrobiotaβ-lactam antibiotic

Identifiers

PMID34531857
PMCPMC8438296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.